Immune activation and HIV persistence: implications for curative approaches to HIV infection

Despite complete or near‐complete suppression of human immunodeficiency virus (HIV) replication with combination antiretroviral therapy, both HIV and chronic inflammation/immune dysfunction persist indefinitely. Untangling the association between the virus and the host immune environment during therapy might lead to novel interventions aimed at either curing the infection or preventing the development of inflammation‐associated end‐organ disease. Chronic inflammation and immune dysfunction might lead to HIV persistence by causing virus production, generating new target cells, enabling infecting of activated and resting target cells, altering the migration patterns of susceptible target cells, increasing the proliferation of infected cells, and preventing normal HIV‐specific clearance mechanisms from function. Chronic HIV production or replication might contribute to persistent inflammation and immune dysfunction. The rapidly evolving data on these issues strongly suggest that a vicious cycle might exist in which HIV persistence causes inflammation that in turn contributes to HIV persistence.

[1]  Jeffrey N. Martin,et al.  Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. , 2013, The Journal of infectious diseases.

[2]  R. Bosch,et al.  CD8+ T-Cell Activation in HIV-1–Infected Patients Experiencing Transient Low-level Viremia During Antiretroviral Therapy , 2013, Journal of acquired immune deficiency syndromes.

[3]  J. Brenchley,et al.  Rate of AIDS progression is associated with gastrointestinal dysfunction in SIV-infected pigtail macaques (P3045) , 2013, The Journal of Immunology.

[4]  J. García,et al.  Impact of highly active antiretroviral therapy initiation on CD4+ T-cell repopulation in duodenal and rectal mucosa , 2013, AIDS.

[5]  J. Brenchley,et al.  Rate of AIDS Progression Is Associated with Gastrointestinal Dysfunction in Simian Immunodeficiency Virus–Infected Pigtail Macaques , 2013, The Journal of Immunology.

[6]  D. Richman,et al.  Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA. , 2013, The Journal of infectious diseases.

[7]  C. Deming,et al.  Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. , 2013, The Journal of clinical investigation.

[8]  R. Kaul,et al.  HIV infection deregulates innate immunity to malaria despite combination antiretroviral therapy , 2013, AIDS.

[9]  G. Pantaleo,et al.  Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production , 2013, The Journal of experimental medicine.

[10]  L. Weiss,et al.  The split personality of regulatory T cells in HIV infection. , 2013, Blood.

[11]  L. Rolnitzky,et al.  Plasma Factors During Chronic HIV-1 Infection Impair IL-12 Secretion by Myeloid Dendritic Cells via a Virus-Independent Pathway , 2012, Journal of acquired immune deficiency syndromes.

[12]  Mark Coles,et al.  IL-7-producing stromal cells are critical for lymph node remodeling. , 2012, Blood.

[13]  M. Lederman,et al.  Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome. , 2012, Blood.

[14]  B. Clotet,et al.  Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery , 2012, AIDS.

[15]  J. Lifson,et al.  Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections. , 2012, Blood.

[16]  Jeffrey N. Martin,et al.  A Randomized Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection , 2012, Journal of acquired immune deficiency syndromes.

[17]  R. Johnson,et al.  SIV infection induces accumulation of plasmacytoid dendritic cells in the gut mucosa. , 2012, The Journal of infectious diseases.

[18]  J. Lifson,et al.  Preclinical evaluation of HIV eradication strategies in the simian immunodeficiency virus-infected rhesus macaque: a pilot study testing inhibition of indoleamine 2,3-dioxygenase. , 2012, AIDS research and human retroviruses.

[19]  M. Carrington,et al.  Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers , 2012, AIDS.

[20]  J. Zamora,et al.  The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients , 2012, AIDS.

[21]  J. van Lunzen,et al.  Expansion of HIV-specific T follicular helper cells in chronic HIV infection. , 2012, The Journal of clinical investigation.

[22]  Michael Y. Gerner,et al.  CD4 T follicular helper cell dynamics during SIV infection. , 2012, The Journal of clinical investigation.

[23]  R. Ribeiro,et al.  Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates. , 2012, Blood.

[24]  D. Montefiori,et al.  Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines , 2012, Nature Medicine.

[25]  C. Tremblay,et al.  Foxo3a: an integrator of immune dysfunction during HIV infection. , 2012, Cytokine & growth factor reviews.

[26]  R. Fromentin,et al.  The role of cytokines in the establishment, persistence and eradication of the HIV reservoir. , 2012, Cytokine & growth factor reviews.

[27]  M. Lederman,et al.  Towards an HIV cure: a global scientific strategy , 2012, Nature Reviews Immunology.

[28]  P. Sax,et al.  Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir , 2012, AIDS.

[29]  S. Sieg,et al.  Faculty Opinions recommendation of Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. , 2012 .

[30]  F. Bushman,et al.  Directly Infected Resting CD4+T Cells Can Produce HIV Gag without Spreading Infection in a Model of HIV Latency , 2012, PLoS pathogens.

[31]  S. Lewin,et al.  Virologically Suppressed HIV Patients Show Activation of NK Cells and Persistent Innate Immune Activation , 2012, The Journal of Immunology.

[32]  A. Lackner,et al.  IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques , 2012, Mucosal Immunology.

[33]  R. Bosch,et al.  CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies. , 2012, The Journal of infectious diseases.

[34]  A. Perelson,et al.  Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection , 2012, Proceedings of the National Academy of Sciences.

[35]  M. Leal,et al.  Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy. , 2012, The Journal of infectious diseases.

[36]  G. Freeman,et al.  PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques. , 2012, The Journal of clinical investigation.

[37]  A. Maisa,et al.  HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy , 2012, AIDS.

[38]  J. Luban,et al.  TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling. , 2012, Current opinion in virology.

[39]  M. Lederman,et al.  Increased Platelet and Microparticle Activation in HIV Infection: Upregulation of P-Selectin and Tissue Factor Expression , 2012, Journal of acquired immune deficiency syndromes.

[40]  C. Tremblay,et al.  The Colocalization Potential of HIV-Specific CD8+ and CD4+ T-Cells is Mediated by Integrin β7 but Not CCR6 and Regulated by Retinoic Acid , 2012, PloS one.

[41]  D. Douek,et al.  Microbial translocation across the GI tract. , 2012, Annual review of immunology.

[42]  R. Siliciano,et al.  Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. , 2012, Immunity.

[43]  J. Qin,et al.  Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease , 2012, PloS one.

[44]  G. Silvestri,et al.  Natural SIV Hosts: Showing AIDS the Door , 2012, Science.

[45]  G. Silvestri,et al.  CD4+ T Cells and HIV: A Paradoxical Pas de Deux , 2012, Science Translational Medicine.

[46]  E. Rosenberg,et al.  HIV-Specific Cytolytic CD4 T Cell Responses During Acute HIV Infection Predict Disease Outcome , 2012, Science Translational Medicine.

[47]  B. Clotet,et al.  Treatment Intensification with Raltegravir in Subjects with Sustained HIV-1 Viraemia Suppression: A Randomized 48-Week Study , 2012, Antiviral therapy.

[48]  D. Price,et al.  Clonotype and Repertoire Changes Drive the Functional Improvement of HIV-Specific CD8 T Cell Populations under Conditions of Limited Antigenic Stimulation , 2012, The Journal of Immunology.

[49]  P. Massip,et al.  Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. , 2012, The Journal of clinical investigation.

[50]  Myron S. Cohen,et al.  Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission , 2011, Science Translational Medicine.

[51]  T. Greenough,et al.  Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoir , 2011, AIDS.

[52]  J. Brenchley,et al.  SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination. , 2011, Blood.

[53]  Jeffrey N. Martin,et al.  Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy , 2011, AIDS.

[54]  A. Zolopa,et al.  Association of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults , 2011, PloS one.

[55]  M. Lederman,et al.  Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. , 2011, The Journal of infectious diseases.

[56]  E. Rosenberg,et al.  Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. , 2011, The Journal of infectious diseases.

[57]  Suha M. Saleh,et al.  Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells , 2011, Retrovirology.

[58]  R. Balderas,et al.  Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis. , 2011, The Journal of clinical investigation.

[59]  A. Weyrich,et al.  Homeostatic Proliferation Fails to Efficiently Reactivate HIV-1 Latently Infected Central Memory CD4+ T Cells , 2011, PLoS pathogens.

[60]  R. Johnson,et al.  Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection. , 2011, Blood.

[61]  G. Silvestri,et al.  Plasmacytoid dendritic cells are recruited to the colorectum and contribute to immune activation during pathogenic SIV infection in rhesus macaques. , 2011, Blood.

[62]  M. Roederer,et al.  IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques. , 2011, Blood.

[63]  Ron Milo,et al.  Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy , 2011, Nature.

[64]  G. Silvestri,et al.  Generalized immune activation and innate immune responses in simian immunodeficiency virus infection. , 2011, Current opinion in HIV and AIDS.

[65]  A. d’Arminio Monforte,et al.  Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count , 2011, AIDS.

[66]  R. Lempicki,et al.  Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes. , 2011, Blood.

[67]  E. Rosenberg,et al.  Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. , 2011, The Journal of infectious diseases.

[68]  Susan Moir,et al.  Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy. , 2011, The Journal of infectious diseases.

[69]  D. Boulware,et al.  Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. , 2011, The Journal of infectious diseases.

[70]  J. Reynes,et al.  Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection. , 2011, Blood.

[71]  Jeffrey N. Martin,et al.  Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. , 2011, The Journal of infectious diseases.

[72]  G. Carcelain,et al.  HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. , 2011, Blood.

[73]  S. Lewin,et al.  Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection. , 2011, Biomarkers in medicine.

[74]  A. Diefenbach,et al.  Control of epithelial cell function by interleukin‐22‐producing RORγt+ innate lymphoid cells , 2011, Immunology.

[75]  Jeffrey N. Martin,et al.  A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. , 2011, The Journal of infectious diseases.

[76]  G. d’Ettorre,et al.  HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS. , 2011, Current HIV research.

[77]  R. Kaul,et al.  Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy , 2011, AIDS.

[78]  Handan Wand,et al.  Plasma levels of soluble CD14 independently predict mortality in HIV infection. , 2011, The Journal of infectious diseases.

[79]  J. Carlis,et al.  Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. , 2011, The Journal of clinical investigation.

[80]  Jeffrey N. Martin,et al.  HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  Christopher Wilhelm,et al.  CD4 and CD8 T Cell Immune Activation during Chronic HIV Infection: Roles of Homeostasis, HIV, Type I IFN, and IL-7 , 2011, The Journal of Immunology.

[82]  P. Nigam,et al.  Loss of IL-17–Producing CD8 T Cells during Late Chronic Stage of Pathogenic Simian Immunodeficiency Virus Infection , 2011, The Journal of Immunology.

[83]  M. Lederman,et al.  HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy , 2011, AIDS.

[84]  A. Sharrett,et al.  T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women , 2011, The Journal of infectious diseases.

[85]  L. Kuller,et al.  Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection , 2011, Journal of acquired immune deficiency syndromes.

[86]  D. Fuchs,et al.  Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy , 2010, Journal of acquired immune deficiency syndromes.

[87]  Jack T Stapleton,et al.  The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation , 2010, Science.

[88]  C. B. Hare,et al.  Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. , 2010, The Journal of infectious diseases.

[89]  G. Ginsberg,et al.  Disruption of Intestinal CD4+ T Cell Homeostasis Is a Key Marker of Systemic CD4+ T Cell Activation in HIV-Infected Individuals , 2010, The Journal of Immunology.

[90]  C. B. Hare,et al.  Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy , 2010, AIDS.

[91]  G. Stewart,et al.  Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation. , 2010, The Journal of infectious diseases.

[92]  P. Roques,et al.  Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion , 2010, Retrovirology.

[93]  G. Boucher,et al.  Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton , 2010, Proceedings of the National Academy of Sciences.

[94]  M. Lederman,et al.  The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial , 2010, PLoS medicine.

[95]  S. Pittaluga,et al.  Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections , 2010, PLoS pathogens.

[96]  D. Douek,et al.  Nonprogressive and progressive primate immunodeficiency lentivirus infections. , 2010, Immunity.

[97]  A. d’Arminio Monforte,et al.  Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART , 2010, AIDS.

[98]  D. Jacobs,et al.  Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. , 2010, The Journal of infectious diseases.

[99]  A. Telenti,et al.  Host and Viral Genetic Correlates of Clinical Definitions of HIV-1 Disease Progression , 2010, PloS one.

[100]  R. Johnson,et al.  CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. , 2010, Blood.

[101]  A. Trkola,et al.  HIV-1 replication activates CD4+ T cells with specificities for persistent herpes viruses , 2010, EMBO molecular medicine.

[102]  M. Wallet,et al.  Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy , 2010, AIDS.

[103]  Jeff E. Mold,et al.  Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease , 2010, Science Translational Medicine.

[104]  Sarah Palmer,et al.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects , 2010, Nature Medicine.

[105]  J. Lifson,et al.  Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation and IL-17 production in the absence of SIV infection , 2010, Mucosal Immunology.

[106]  S J Gange,et al.  Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[107]  M. Paiardini Th17 cells in natural SIV hosts , 2010, Current opinion in HIV and AIDS.

[108]  J. Brenchley,et al.  Th17 cell dynamics in HIV infection , 2010, Current opinion in HIV and AIDS.

[109]  S. Khader,et al.  Th17 cytokines in mucosal immunity and inflammation , 2010, Current opinion in HIV and AIDS.

[110]  C. Tremblay,et al.  Potential role of IL-18 in the immunopathogenesis of AIDS, HIV-associated lipodystrophy and related clinical conditions. , 2010, Current HIV research.

[111]  C. Tremblay,et al.  HIV-1 causes an imbalance in the production of interleukin-18 and its natural antagonist in HIV-infected individuals: implications for enhanced viral replication. , 2010, The Journal of infectious diseases.

[112]  Jeffrey N. Martin,et al.  Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV Disease , 2010, PloS one.

[113]  M. Lederman,et al.  Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. , 2010, Blood.

[114]  P. Nigam,et al.  Expansion of FOXP3+ CD8 T Cells with Suppressive Potential in Colorectal Mucosa Following a Pathogenic Simian Immunodeficiency Virus Infection Correlates with Diminished Antiviral T Cell Response and Viral Control , 2010, The Journal of Immunology.

[115]  Alan S. Perelson,et al.  CD8+ Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells , 2010, PLoS pathogens.

[116]  S. Pillai,et al.  In Vivo CD8+ T-Cell Suppression of SIV Viremia Is Not Mediated by CTL Clearance of Productively Infected Cells , 2010, PLoS pathogens.

[117]  R. Kaul,et al.  The integrin α4β7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1 , 2009, Proceedings of the National Academy of Sciences.

[118]  M. Proschan,et al.  Cycling of Gut Mucosal CD4+ T Cells Decreases after Prolonged Anti-Retroviral Therapy and is Associated with Plasma LPS Levels , 2009, Mucosal Immunology.

[119]  J. Carlis,et al.  Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. , 2009, The Journal of clinical investigation.

[120]  P. Massip,et al.  HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy , 2009, PloS one.

[121]  M. King,et al.  Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells. , 2009, The Journal of infectious diseases.

[122]  L. Kuller,et al.  Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. , 2009, The Journal of infectious diseases.

[123]  A. Lackner,et al.  Monitoring α4β7 integrin expression on circulating CD4+ T cells as a surrogate marker for tracking intestinal CD4+ T-cell loss in SIV infection , 2009, Mucosal Immunology.

[124]  Geneviève Boucher,et al.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation , 2009, Nature Medicine.

[125]  B. Agan,et al.  Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression. , 2009, The Journal of infectious diseases.

[126]  S J Gange,et al.  Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy , 2009, Proceedings of the National Academy of Sciences.

[127]  K. Williams,et al.  HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesis , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[128]  M. Lederman,et al.  Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. , 2009, The Journal of infectious diseases.

[129]  Susan Moir,et al.  B cells in HIV infection and disease , 2009, Nature Reviews Immunology.

[130]  Jeffrey N. Martin,et al.  Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[131]  M. Cloyd,et al.  HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression. , 2009, International immunology.

[132]  Carole R. Baskin,et al.  Critical Loss of the Balance between Th17 and T Regulatory Cell Populations in Pathogenic SIV Infection , 2009, PLoS pathogens.

[133]  R. Shafer,et al.  Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[134]  Mila Lebedeva,et al.  Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.

[135]  D. Follmann,et al.  HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells , 2008, Proceedings of the National Academy of Sciences.

[136]  A. Phillips,et al.  The role of HIV in serious diseases other than AIDS , 2008, AIDS.

[137]  A. Fauci,et al.  The Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands , 2008, The Journal of Immunology.

[138]  J. Benito,et al.  Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy. , 2008, The Journal of infectious diseases.

[139]  A. Trkola,et al.  HIV rebounds from latently infected cells, rather than from continuing low-level replication , 2008, Proceedings of the National Academy of Sciences.

[140]  Lewis H Kuller,et al.  Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection , 2008, PLoS medicine.

[141]  C. Tincati,et al.  Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy , 2008, AIDS.

[142]  D. Douek,et al.  Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. , 2008, Blood.

[143]  Xiaoxu Han,et al.  Relationship of frequency of CD4+CD25+Foxp3+ regulatory T cells with disease progression in antiretroviral-naive HIV-1 infected Chinese. , 2008, Japanese journal of infectious diseases.

[144]  A. Haase,et al.  Collagen deposition limits immune reconstitution in the gut. , 2008, The Journal of infectious diseases.

[145]  A. Haase,et al.  Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques , 2008, The Journal of Immunology.

[146]  Wei Wang,et al.  Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals , 2008, The Journal of experimental medicine.

[147]  R. Kaul,et al.  Immune reconstitution in the sigmoid colon after long-term HIV therapy , 2008, Mucosal Immunology.

[148]  K. Strebel,et al.  HIV-1 Vif, APOBEC, and Intrinsic Immunity , 2008, Retrovirology.

[149]  A. Haase,et al.  The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche. , 2008, Seminars in immunology.

[150]  Daniel C. Douek,et al.  CD127 and CD25 Expression Defines CD4+ T Cell Subsets That Are Differentially Depleted during HIV Infection 1 , 2008, The Journal of Immunology.

[151]  M. Moroni,et al.  Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection , 2008, Antiviral therapy.

[152]  R. Xavier,et al.  IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. , 2008, The Journal of clinical investigation.

[153]  V. Appay,et al.  Immune activation and inflammation in HIV‐1 infection: causes and consequences , 2008, The Journal of pathology.

[154]  Suha M. Saleh,et al.  CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. , 2007, Blood.

[155]  B. Walker,et al.  Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. , 2007, Immunity.

[156]  D. Vittecoq,et al.  Cytokines in HIV-associated cardiomyopathy. , 2007, International journal of cardiology.

[157]  Claus O Wilke,et al.  Limits on Replenishment of the Resting CD4+ T Cell Reservoir for HIV in Patients on HAART , 2007, PLoS pathogens.

[158]  B. Gazzard,et al.  HIV-1 Viral Replication below 50 Copies/ml in Patients on Antiretroviral Therapy is not associated with CD8+ T-cell Activation , 2007, Antiviral therapy.

[159]  Mario Roederer,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.

[160]  Roger Detels,et al.  Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection. , 2007, JAMA.

[161]  A. Sönnerborg,et al.  Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection , 2007, AIDS.

[162]  R. Mazzucchelli,et al.  Interleukin-7 receptor expression: intelligent design , 2007, Nature Reviews Immunology.

[163]  L. Greller,et al.  Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells , 2007, The Journal of experimental medicine.

[164]  J. Brenchley,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.

[165]  M. Markowitz,et al.  Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection , 2006, PLoS medicine.

[166]  A. Esposito,et al.  T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART , 2006, AIDS.

[167]  R. Koup,et al.  PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection , 2006, The Journal of experimental medicine.

[168]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[169]  Alan S. Perelson,et al.  Viral and Latent Reservoir Persistence in HIV-1–Infected Patients on Therapy , 2006, PLoS Comput. Biol..

[170]  M. Clerici,et al.  Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART , 2006, AIDS.

[171]  Mario Roederer,et al.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.

[172]  V. Maino,et al.  IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. , 2006, The Journal of clinical investigation.

[173]  Fernando Aiuti,et al.  Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. , 2006, AIDS reviews.

[174]  D. Watkins,et al.  Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. , 2006, The Journal of infectious diseases.

[175]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[176]  D. Nickle,et al.  HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. , 2005, The Journal of clinical investigation.

[177]  P. Price,et al.  Dysregulation of CD28 and CTLA‐4 expression by CD4 T cells from previously immunodeficient HIV‐infected patients with sustained virological responses to highly active antiretroviral therapy , 2005, HIV medicine.

[178]  C. Rinaldo,et al.  Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approaches. , 2005, AIDS reviews.

[179]  S. Kent,et al.  Induction of T-Cell Immunity to Antiretroviral Drug-Resistant Human Immunodeficiency Virus Type 1 , 2005, Journal of Virology.

[180]  Matthew C Strain,et al.  Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. , 2005, The Journal of infectious diseases.

[181]  D. Follmann,et al.  Compromised B cell responses to influenza vaccination in HIV-infected individuals. , 2005, The Journal of infectious diseases.

[182]  Mario Roederer,et al.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.

[183]  M. Thomson,et al.  IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. , 2005, The Journal of clinical investigation.

[184]  Jessica M Malenfant,et al.  Increased Natural Killer Cell Activity in Viremic HIV-1 Infection1 , 2004, The Journal of Immunology.

[185]  G. Pantaleo,et al.  Phenotypic heterogeneity of antigen‐specific CD4 T cells under different conditions of antigen persistence and antigen load , 2004, European journal of immunology.

[186]  Peter Hunt,et al.  Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. , 2004, Blood.

[187]  P. Schwarzenberger,et al.  Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. , 2004, The Journal of infectious diseases.

[188]  J. Benito,et al.  The role of CD8+ T-cell response in HIV infection. , 2004, AIDS reviews.

[189]  D. Montefiori,et al.  Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication. , 2004, The Journal of clinical investigation.

[190]  Tao Dong,et al.  Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection , 2004, PLoS biology.

[191]  J. Flamm,et al.  Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.

[192]  R. Siliciano,et al.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells , 2003, Nature Medicine.

[193]  R. Dersimonian,et al.  Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. , 2003, Journal of acquired immune deficiency syndromes.

[194]  Jeffrey N. Martin,et al.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. , 2003, The Journal of infectious diseases.

[195]  T. Chun,et al.  Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[196]  Y. Korin,et al.  Interleukin-7 Induces Expression of Latent Human Immunodeficiency Virus Type 1 with Minimal Effects on T-Cell Phenotype , 2002, Journal of Virology.

[197]  Giuseppe Nunnari,et al.  Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy. , 2002, The Journal of infectious diseases.

[198]  Alan S. Perelson,et al.  In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4+ but not CD8+ T cells depleted? , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[199]  Ryung S. Kim,et al.  Limited immune restoration after 3 years’ suppression of HIV-1 replication in patients with moderately advanced disease , 2002, AIDS.

[200]  T. Chun,et al.  Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy. , 2002, The Journal of infectious diseases.

[201]  Z. Grossman,et al.  HIV preferentially infects HIV-specific CD4+ T cells , 2002, Nature.

[202]  G. Trinchieri,et al.  Persistent Decreases in Blood Plasmacytoid Dendritic Cell Number and Function Despite Effective Highly Active Antiretroviral Therapy and Increased Blood Myeloid Dendritic Cells in HIV-Infected Individuals1 , 2002, The Journal of Immunology.

[203]  M. Lederman,et al.  CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection. , 2002, Clinical immunology.

[204]  R. Koup,et al.  Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.

[205]  M. Mulligan,et al.  Polymorphisms in HLA Class I Genes Associated with both Favorable Prognosis of Human Immunodeficiency Virus (HIV) Type 1 Infection and Positive Cytotoxic T-Lymphocyte Responses to ALVAC-HIV Recombinant Canarypox Vaccines , 2001, Journal of Virology.

[206]  T. Chun,et al.  HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[207]  M. Lederman Immune restoration and CD4+ T-cell function with antiretroviral therapies , 2001, AIDS.

[208]  A. Lafeuillade,et al.  Pilot Study of a Combination of Highly Active Antiretroviral Therapy and Cytokines to Induce HIV‐1 Remission , 2001, Journal of acquired immune deficiency syndromes.

[209]  J. Schmitz,et al.  Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys. , 2000, Blood.

[210]  C H Fox,et al.  Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy. , 1999, AIDS.

[211]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[212]  D. Littman,et al.  Cytokine Signals Are Sufficient for HIV-1 Infection of Resting Human T Lymphocytes , 1999, The Journal of experimental medicine.

[213]  M. Dybul,et al.  Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy , 1999, Nature Medicine.

[214]  J. Lisziewicz,et al.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.

[215]  R. Detels,et al.  CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[216]  T. Chun,et al.  Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[217]  Anthony S. Fauci,et al.  Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines , 1998, The Journal of experimental medicine.

[218]  R. Siliciano,et al.  Viral Dynamics in HIV-1 Infection , 1998, Cell.

[219]  Z. Grossman,et al.  Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[220]  J. Montaner,et al.  Association of Phenotypic Changes in B Cell Lymphocytes and Plasma Viral Load in Human Immunodeficiency Virus-Infected Patients , 1998, Journal of Clinical Immunology.

[221]  R P Johnson,et al.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. , 1998, Science.

[222]  M A Nowak,et al.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[223]  D. Richman,et al.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.

[224]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[225]  R. Phillips,et al.  Antagonism of cytotoxic T lymphocyte‐mediated lysis by natural HIV‐1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides , 1997, European journal of immunology.

[226]  M. Gottlieb,et al.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. , 1981, The New England journal of medicine.

[227]  M. Sinet,et al.  Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection. , 2012, The Journal of infectious diseases.

[228]  J. Brenchley,et al.  Microbial translocation, immune activation, and HIV disease. , 2013, Trends in microbiology.

[229]  J. Routy,et al.  CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[230]  M. Benkirane,et al.  How SAMHD1 changes our view of viral restriction. , 2012, Trends in immunology.

[231]  G. Alter,et al.  KIR/HLA: genetic clues for a role of NK cells in the control of HIV. , 2011, Advances in experimental medicine and biology.

[232]  D. Torre,et al.  Interleukin 18 and cardiovascular disease in HIV-1 infection: a partner in crime? , 2010, AIDS reviews.

[233]  V. Velu,et al.  InfectionLate Chronic Stage of Pathogenic SIV Producing CD8 T Cells during - Loss of IL-17 , 2010 .

[234]  D. Douek,et al.  HIV infection and the gastrointestinal immune system , 2008, Mucosal Immunology.

[235]  J. Benito,et al.  T regulatory cells and HIV infection. , 2007, AIDS reviews.

[236]  R. Grant,et al.  Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis , 2001, Nature Medicine.